| INTRODUCTION
Abdominal pain is a commonly experienced and debilitating symptom of IBD, with up to 70% of patients experiencing pain when the disease is active. [1] [2] [3] Common causes of IBD-related abdominal pain include acute inflammation, strictures, adhesions, small-bowel obstruction and bowel dysmotility. 4 Reducing abdominal pain is a key therapeutic target for IBD therapy; however, pain severity does not always correlate with endoscopic and clinical biomarkers, and a significant proportion of patients (20-50%) report ongoing pain during periods of remission. 3, [5] [6] [7] Bodily pain, cramps and extra intestinal manifestations of IBD such as arthralgia are also reported by patients. 3, 8 In an IBD population-based cohort, peripheral arthritis and non-inflammatory joint pain were reported by 0.4% and 16% of patients, respectively. 9 The prevalence of chronic widespread pain or fibromyalgia has ranged between 3.5 and 30% in adults with IBD. 10, 11 Suggested causes of extra intestinal manifestations of pain in IBD include genetic predisposition, such as polymorphisms of the NOD2 gene involved in the transcription of proinflammatory cytokines and chemokines, or the migration of gut lymphocytes. 9, 12 Research has shown the capacity of activated intestinal lymphocytes to enter the joints and adhere to inflamed synovial vessels. 13 Such processes within the 'joint-gut axis' are suggested to explain the high co-occurrence of IBD and arthropathies; however, research into this area of IBD-pain has received much less attention.
Chronic pain in IBD is a complex phenomenon driven by a range of peripheral and central nervous system (CNS) processes. In the case of acute pain, noxious signalling is processed by sensory afferent nerves that innervate the gut wall and send signals from the lower gastrointestinal tract to the CNS via the dorsal spinal horn. 14 However, recurrent inflammation and release of mucosal signalling molecules (eg nerve growth factor, glial cell-lined derived neurotrophic factor and ion channel expression TRPV1/TRPA1) in the context of chronic IBD can result in visceral hypersensitivity. 1, 14 In CNS processing, recurrent visceral stimulation can lead to the activation of the N-methyl-D-aspartate receptor and influx of calcium in higher/second-order sensory neurons, resulting in long-lasting neuronal excitability in the absence of inflammation. 15 Central processing within the brain such as stress and arousal may also have a role in pain perception and aetiology of chronic IBD-pain, such as via mechanisms along the 'brain-gut' axis. Stress can exacerbate IBD symptoms by the production of cortisol and catecholamines from the hypothalamic-pituitary-adrenal and sympathetic-adrenal-medullary axis and thereby the release of circulating inflammatory cytokines (eg IL-6). 16, 17 Emotional and cognitive processes can also amplify perception of incoming visceral signals by modulating descending inhibitory processes. 18 Similar mechanisms have been recognised in irritable bowel syndrome (IBS), and functional symptoms in quiescent IBD are frequently entangled with a diagnosis of IBS. 19, 20 However, there is mixed support as to whether conceptualising symptoms in quiescent IBD as IBS is useful.
Current treatments for pain management in IBD carry a number of risks and limitations. Escalating pharmacotherapy or exploratory surgery for pain in the absence of inflammation can have iatrogenic side effects, potentially exacerbating disease activity, psychological distress and worsening quality of life for patients. Alternative options such as antispasmodics, anticonvulsants, tricyclic antidepressants and cyclooxygenase-2 (COX-2) inhibitors may provide pain relief, yet their long-term use can exacerbate gut symptoms and bowel dysmotility. 17 A significant number of patients use opioids or marijuana for pain control despite psychological and disease-related risks. [21] [22] [23] [24] In a European IBD cohort (n = 2831), 21 .5% and 14.7% of patients were reported to take antidepressant or opioid medication respectively. 25 Norton et al 26 recently reviewed abdominal pain management interventions in IBD and found promising evidence for psychological approaches for IBD-pain. For example, self-directed and therapist-led stress management, 27 coping skills 28 and disease anxiety-related cognitive-behavioural therapy (CBT), 29 all appear to attenuate abdominal pain symptoms, albeit in predominantly small samples. Adjuvant psychological therapy may be particularly effective for individuals with IBD in pain, at risk of psychological distress and who are experiencing ongoing symptoms in the absence of active disease. 30 Yet the review highlighted the need for evidence-based theory to aid the development of effective psychosocial interventions for IBD-pain. it is yet to be thoroughly investigated.
Despite pain being rated as one of patients' most bothersome symptoms in IBD, 31, 32 this remains an area of limited research. In addition to the disease, the symptom of pain specifically has a profound impact on the quality of life and functioning of IBD patients. 3 To date, systematic reviews in IBD have explored the role of psychosocial factors on the course of IBD and associated psychotherapeutic approaches, 33 psychosocial correlates of adjustment in IBD 34 and pain management interventions in IBD. 26 However, a systematic review of psychosocial factors in IBD-pain specifically is lacking. A comprehensive profile of psychological and social factors associated with pain in IBD will provide a basis for developing a theory of IBDpain to underpin a psychosocial intervention, as has been applied in other conditions such as multiple sclerosis and paediatric chronic fatigue syndrome. 35, 36 Specific aims of the study are:
1. To systematically review psychological and social factors associated with pain in adults diagnosed with IBD.
2.
To assess the association of pain and clinical and sociodemographic factors within included studies of psychosocial investigations.
| ME TH ODS
The protocol for this review was prospectively registered on 23/03/ 2017 (PROSPERO 42016052479).
| Eligibility criteria
Studies were eligible if they reported on pain in an adult IBD population and measured at least 1 psychosocial factor. Studies including paediatric populations were not included, as it was contended that psychological processes compared to adult IBD-pain were likely to be different, for example the role of parent-child dyads. A focus on adult IBD-pain would therefore yield greater clarity in identifying key targets for a self-management intervention. Pain measures included any pain measure such as pain intensity, severity, diagnosis of chronic pain (>3 months), pain-associated disability or interference. Inclusion and exclusion criteria for this review are presented in Table 1 however, no restrictions were applied with regard to publication date due to the limited number of studies on psychosocial factors and pain in IBD. L.S. and L.M. independently carried out abstract and full-text screening using predetermined criteria. Any disagreements between reviewers were resolved through discussion utilising inclusion criteria.
| Data collection
Predefined data extraction criteria were used by 2 authors (L.S. and L.M.) to extract relevant data. Any discrepancies were again resolved by consensus or inclusion of a third author (C.N). Extracted information from each study included (1) study design (2) number of participants, (3) characteristics of patient sample (age, IBD diagnosis), (4) comparator group (if applicable) (5) recruitment source (6) type of (correlate) psychosocial measure, (7) type of (outcome) pain measure, 
| Quality assessment
Methodological quality of studies was assessed using the Critical Appraisal Skills Programme (CASP) guidelines, selected by the specific methodological design of included studies. 37 The same criteria have been applied in previous reviews on IBD populations. (Table S1 ). As all papers were considered to contribute to the topic of interest, no studies were excluded on the basis of quality.
3 | RESULTS
| Study characteristics
Combined database and manual searches identified 3336 references.
After removing duplicates and undertaking title and abstract screen- Table S2 .
| Results of individual studies
The 15 studies included a total of 5539 IBD participants (including indeterminate colitis) and 993 non-IBD participants. A wide variety of pain measures were used in studies, with a significant proportion of studies relying on single-item questions or sub-scores to assess pain.
Moreover, there was wide variability in study design and methodology. Eight studies were cohort studies and 7 were case-control stud- geal reflux disease. [42] [43] [44] [45] One study was longitudinal and 14 studies were cross-sectional design, of which one was baseline data from an intervention study 46 and 2 were national cohort survey studies. 47, 48 A summary of included studies is provided in Table 3 , with detailed results of each included study presented in Table S1 . Twenty-five psychosocial factors in relation to pain were identified, including emotional, cognitive, behavioural and personality factors. Ten and 5 studies conducted univariate and multivariate analyses respectively (Table 4) . A variety of pain presentations were investigated and different pain measures were used by the studies (Table 5) .
Two papers explored different pain presentations (Tripp DA, Walker S, et al, unpublished details), 49 including joint pain, chronic pain with a neuropathic component and migraine. 49 Prevalence of probable migraine and chronic pain were significantly higher in the IBD cohort compared to the general population. 49 Prevalence of patients with IBD with chronic pain in studies ranged from 11.3% to 38%. 2, 49 Percentages of patients experiencing pain of at least moderate intensity at the time of study, or who had experienced pain within the last 3 months, ranged from 21% to 82.5% across studies.
The 25 psychosocial factors identified were grouped into 3 broad categories; emotional, cognitive-behavioural and personality factors, and are reviewed below. Addressing the second aim of the review, clinical and sociodemographic factors associated with pain identified within the reviewed studies are then reported.
| EMOTIONAL FACTORS
One study investigated the presence of a mood disorder (by physician diagnosis) in relation to pain. 50 From multivariate analyses, a co- and/or restricted activities. 48 All but one of these studies was crosssectional in design. Assessing different pain presentations, 1 study found that higher Hospital Anxiety Depression (HAD) depression scores (4th quartile vs 1st quartile) were associated with a 3.44 increased risk of probable migraine, but were not found to correlate with joint pain, abdominal pain or chronic pain with a neuropathic component. 49 In the only longitudinal study identified in this review, pain at baseline correlated with depressive symptoms at baseline and 6 months. 45 Five of these studies used the hospital anxiety depression score (HADS) questionnaire. Two of these studies included a comparison group, namely IBS 42 and patients with arthritis. 49 One study investigating depression stratified participants who had active and inactive disease, defined by colonoscopy and increased abdominal pain/tenderness; however, this was deemed a low-quality study. 42 Exploring the association between anxiety and different pain presentations, HAD anxiety scores significantly correlated with joint and overall pain severity and probable migraine in an IBD cohort, but not abdominal or chronic pain with a neuropathic component in 1 longitudinal study. 49 The HADS questionnaire was used in 1 study to assess factors associated with mood disorders in IBD, 40 and found that abdominal pain was significantly associated with HAD anxiety in CD. Active disease (SCCAI/endoscopic active disease Baron's score >1) and perceived stress independently predicted anxiety and depression scores 
| Stress
Four studies assessed levels of psychological stress, including perceived stress, in relation to pain (Boyle et al, unpublished details). 44, 45, 51 All of these studies found significant and positive correlations between stress and pain intensity (Boyle et al, unpublished details), 44, 45, 51 pain-related interference (Boyle et al, unpublished details) and bodily pain. 51 In regression analyses, odds ratio for psychological stress (OR lowest 2.26, highest 12.17) and female gender (OR highest 3.19) increased with greater pain using 3 pain subscores. 51 Three out of 4 studies were cross-sectional in design; however, 1 longitudinal study found only baseline pain scores correlated with baseline perceived stress. 45 
| COGNITIVE-BEHAVIOURAL FACTORS

| Pain catastrophising
Three studies investigated pain catastrophising, which refers to an exaggerated negative cognitive and affective interpretation of actual pain or an expected pain experience. It includes magnifying potential negative factors associated with pain, feelings of helplessness and an inability to disengage from pain-related thoughts. 55 One high-quality study found that a tendency to catastrophise was a significant predictor of moderate to severe pain after controlling for active disease, measured by the Harvey-Bradshaw index (HBI) or SCCAI. 2 
| Coping
Coping is an important construct in the context of chronic illness, and refers to an individual's efforts to tolerate and resolve stressors that exceed his or her resources. 53 Three cross-sectional studies assessed the association between pain and coping, using a variety of measures. As measured by the coping strategies questionnaire, 1 study found that having a catastrophising tendency predicted moderate to severe pain in multivariate analyses, as aforementioned. 2 However, in univariate analyses, ignoring sensations, praying and hoping, cognitive coping/suppression, helplessness and diverting attention/praying were all found to be significantly correlated to greater pain intensity and associated disability. 2 In this study, chronic pain was present in 38% of patients, of which chronic abdominal pain was the most frequently reported (91%) followed by joint pain (33%), back pain (33%) and chronic headache (33%). 2 Moderate to severe pain was also associated with active disease according to the HBI or SCCAI. Excluding disease activity, there were no differences in other disease characteristics (medication, disease duration) between moderate-severe and mild pain reporters. Coping strategies were investigated in 1 study, which assessed pain in participants recruited online and in clinics, through pain sub-scales in the HBI, Short inflammatory bowel disease questionnaire and Short Form 36. 51 These included emotion-focused coping (eg acceptance, humour, and emotional support use), problemfocused coping (eg active coping and planning) and unhelpful or 'dysfunctional' coping (eg self-blame, denial and substance use). For the whole cohort, use of 'dsyfunctional' strategies was the only coping strategy that significantly correlated with severe pain across all 3 pain sub-scores (P <0.001). In logistic regression analyses, dysfunctional coping showed significant increased odd ratios with mild pain (OR 1.06 in HBI and SF-36) and moderate pain (OR 1.07
T A B L E 5 List of pain presentations and pain measures in reviewed studies
in SIBDQ) (both P <0.05). From the SIBDQ pain sub-score, use of problem-focused coping was associated with a 15% reduced risk of experiencing severe pain (P <0.05). Emotion-focused coping showed no significant association with pain across pain sub-scores. beliefs in the effectiveness of pain medication were found to be associated with greater pain in multivariate analyses in another study. 2 In univariate analyses of this study, the extent to which participants believed that they were disabled by pain (disability score) significantly correlated with pain. A positive psychological factor, perceived social support, was significantly associated with less pain in 1 high-quality cross-sectional study (Tripp DA, Hayley D, et al, unpublished details); however, this was not supported in a prospective study which found no association with social support and pain levels. 45 
| Pain fear avoidance
Pain fear avoidance was investigated in IBD patients diagnosed with chronic pain, along with patients with back pain and heterogonous pain conditions (eg fibromyalgia and spinal pain syndromes). 43 This construct explores individual's beliefs of fearful or threatening situations, and is argued to exacerbate deconditioning and disability in the context of chronic pain. 54 In a cross-sectional design, pain intensity correlated with pain fear avoidance across all 3 groups. No data were provided on disease activity.
| PERSONALITY FACTORS
Personality factors and bodily pain within a health-related quality of life (HRQoL) measure was investigated in 1 study. 46 Patients were recruited on the basis of a disease activity index for CD or UC of >4
(active disease) and perceived stress questionnaire score of > 60. In CD patients only, greater scores on a bodily pain sub-scale (demonstrating better pain-related quality of life) was associated with internal locus of control (P = 0.04). In regression analyses, although the overall model (including control variables) was not found to be significant in explaining bodily pain, the personality variable of internal locus of control remained significant. Pain levels were not associated with positive personality traits of gratitude, benefit finding or thriving in the only included longitudinal study. between an inflammatory marker (C-reactive protein) and pain. 50 Abdominal pain showed no association with disease activity in 2 studies 41, 49 and active disease only predicted pain in UC but not CD patients in another study. 46 Three studies found that psychosocial factors remained significant predictors of pain alongside active disease or markers of inflammation. 2, 41, 49, 50 One study found that depression remained the only significant predictor of pain ratings when controlling for clinical factors (r> .50). 41 This study investigated the influence of ion channel density and neurotrophic factors on pain, which are upregulated as a result of inflammatory activity and can lead to visceral hypersensitivity. 1 In univariate analyses, higher NRTN and lower TRPA1 levels in the mucosa correlated with higher pain ratings. Endoscopic findings and cytokine inflammatory markers (IL 1b, IL6, IL17) did not correlate with pain ratings. 41 Disease duration was associated with probable migraine, 49 but not found to be significantly associated with pain ratings in another study (Boyle et al, unpublished details). With regard to medication use, 2 studies found that no IBD-specific medications were associated with overall pain risk 2,49 and 1 found that only use of NSAIDS was significantly greater in the abdominal pain group. 50 As expected, opiate and paracetamol use increased in relation to pain severity groups in 2 2, 50 and 3 studies respectively (Boyle et al, unpublished details).
2,50
Seven studies assessed the relationship between gender and pain, and 3 found a significant association with pain and female gender, [49] [50] [51] including greater prevalence of migraine in females. 49 Younger age was associated with greater pain 41, 50 and probable migraine. 49 In quiescent IBD, 1 study found that patients reporting frequent to constant levels of pain were significantly more likely to have a co-existing diagnosis of a mood disorder, a chronic pain syndrome, a diagnosis of IBS, were more likely to be female, be younger and have higher ESR (mm/hr) values. Exacerbation of pain symptoms from emotional arousal may also link to cognitive-behavioural factors. Greater catastrophising was associated with pain across several studies, which has been recognised as a contributing factor to chronic pain in conditions such as such as multiple sclerosis and fibromyalgia. 63, 64 Moreover, research in IBS has shown a mediating role of pain catastrophising between depression and abdominal pain. 65 A number of studies examined coping strategies in relation to pain levels (Tripp DA, Hayley D, et al, unpublished details). 51 Greater use of behaviours such as self-distraction, behavioural disengagement, denial, venting and self-blame (labelled 'dysfunctional' coping) and less use of active coping and planning (labelled 'problem-focused' coping) were related to increased pain severity. Emotionally focused coping strategies (acceptance, humour, positive framing) showed no relation to pain levels. In another reviewed study, both 'wellness' and 'illness'-focused coping were investigated. Wellness-focused coping addresses behaviours that aim to facilitate pain control, such as exercise/stretching, task persistence and relaxation, whereas illnessfocused coping includes withdrawal behaviours and giving up on an attempt to control the pain, such as guarding, resting and asking for assistance. Both types of coping were positively associated with increased pain intensity. These conflicting results suggest that the relation of overarching coping styles to IBD-pain is unclear. One could argue that the use of emotionally focused techniques, such as acceptance and humour, may be adaptive or 'functional' for an individual in a given context. In this regard, identifying specific unhelpful thoughts and behaviours in relation to pain, such as denial, selfblame and fear avoidance, 43 may be more effective targets than overarching coping styles for intervention development.
A number of positive psychological factors were explored in studies identified in the current review. Perceived social support and problem-focused coping were negatively associated with pain (Tripp DA, Hayley D, et al, unpublished details). 51 An internal locus of control, 46 namely the perception that one's behaviour can control events and outcomes was associated with better pain-related quality of life.
Research on chronic back pain has shown that individuals with an external locus of control are more likely to rely on maladaptive coping strategies such as low levels of activity and a lack of belief in recovery. 66, 67 This has been supported in research on IBD cohorts with back and joint pain. 68 Perceived controllability of stressful life events has been investigated in individuals with functional gastrointestinal disorders, and has demonstrated that developing skills of coping flexibility, in particular learning to identify and respond adaptively to controllable vs uncontrollable stressors, may be a useful tool for patients with more complex symptoms. 69 One study found that acceptance of pain signifi- However, this was not supported by one reviewed study. 41 This demonstrates the complexity of identifying clinical factors related to pain in IBD, and requires further clarification. The majority of studies that controlled for disease activity found that psychosocial factors remained significant predictors of pain levels regardless of disease activity. This supports the role of a biopsychosocial approach to IBD-pain, and highlights the need to take an integrative approach when assessing patients' symptoms and quality of life, in periods of both active and inactive disease.
The review identified that females and younger adults may be at 
| LIMITATIONS
Despite identification of key factors associated with pain in IBD, limitations must be acknowledged. Although a number of studies controlled for disease activity, only one stratified results based on patients with active and inactive disease. 50 Patients with active disease were included in the review as studies examining patients only in remission and fulfilling eligibility criteria were sparse in preliminary searches. Therefore, investigation of pain in patients in remission specifically was limited in this review. A substantial number of reviewed studies lacked the inclusion of a specific validated pain measure; 8 out of 15 studies used either the pain sub-measure from HRQoL, disease activity index questionnaires or single items in questionnaire surveys. 47, 48 The use of validated pain scales with broader profile of pain is recommended for pain assessment, including pain location, intensity/severity, pain interference and pain-related beliefs. 76, 77 These constructs are also recommended as key outcome measures in pain clinical trials. 78 Ongoing pain in IBD remission has been discussed in relation to IBS and conceptualised as IBS-IBD or more recently 'irritable inflammatory bowel syndrome'. 79 In support, 1 study found that patients with quiescent UC but reporting frequent to constant levels of pain were more likely to have a diagnosis of IBS (and chronic pain syndromes), alongside a mood disorder. 50 As IBS and IBS-IBD were not the main focus of this review, these were not included in the search terms. In addition, it was felt by the authors that exploration of IBD-pain in isolation rather than the addition of IBS-IBD would have yielded a purer review on IBD-pain, rather than with accompanying gastrointestinal or functional symptoms. At the screening stage, studies were not excluded if they involved IBS-IBD patients, but were excluded if pain was measured only within an IBD or IBS composite score. Therefore, although studies on IBS-IBD were considered for this review pending eligibility criteria, a large number of papers on IBS-IBD or functional symptoms in IBD may have provided a more comprehensive profile of psychosocial factors associated with pain in IBD. In addition, it may have yielded more studies examining IBD patients exclusively in remission.
All but one of the included studies were observational studies, therefore direction of causality cannot be determined. Future research would benefit from longitudinal studies to assess whether psychosocial factors can predict variation in pain ratings over time.
Lastly, only 1 of the 15 included studies carried out a power calculation. 51 Further exploration of psychosocial factors and pain in would be strengthened by prospective studies and use of statistical power analyses. Further recommendations for observational and intervention studies are summarised in Table 6 .
| Clinical implications of key findings
The review suggests a number of implications for clinical practice. A recent systematic review on chronic abdominal pain management in IBD presented promising findings for psychosocial interventions, including stress management techniques and coping skills training. 26 Results from this review support the application of a psychosocial intervention, alongside IBD medication, for pain management. In T A B L E 6 Recommendations for future observational and intervention studies
Study type Recommendations
Observational studies 
| Conclusions and recommendations
This is the first review to systematically explore the role of psychosocial factors related to IBD-pain. The emotional, cognitive, behavioural and personality factors identified here are consistent with other systematic reviews on disease-specific pain and the chronic pain litera- 
